ArticleBreast cancer (Tokyo, Japan)2026

BRCA pathogenic variants and response in early TNBC patients treated with neoadjuvant pembrolizumab: outcomes of the BRCAPATH study.

Bogdan-Valentin Popescu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.